Edgewise Therapeutics Inc (EWTX)
Edgewise Therapeutics - Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM)
Edgewise Therapeutics - Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM)
Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine
Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1β Antibody
Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial
Best Buy Canada Selects Perion as a Full-Stack Partner to Power its Retail DOOH Media Network
FORM 6-K- Company Presentation
Horace Mann Helps Educators Achieve Millions in Student Loan Relief Through Student Loan Solutions Program
Best Buy Canada Selects Perion as a Full-Stack Partner to Power its Retail DOOH Media Network
TD SYNNEX Recognized with Multiple 2026 HPE Partner of the Year Awards Across North America and Europe
Cipher Digital Announces Appointment of Bill Blevins as Head of Grid Strategies